Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Total article views   HTML views PDF downloads Totals
7,443 Dovepress* 6,743+ 1,141 7,884
PubMed Central* 700 188 888
Totals 7,443 1,329 8,772
*Since 26 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 4 6

View citations on PubMed Central and Google Scholar